神经营养因子受体RET驱动血造干细胞的生存和功能
Diogo Fonseca-Pereira1, Sílvia Arroz-Madeira1, Mariana Rodrigues-Campos2
11] Instituto de Medicina Molecular, Faculdade de Medicina de Lisboa, Avenida Professor Egas Moniz, Edifício Egas Moniz, 1649-028 Lisboa, Portugal [2].
神经营养因子受体RET对于造血干细胞 (HSC) 的生存和扩张至关重要. 激活RET可以提高HSC功能和移植效率,提供治疗潜力.
科学领域:
- 血液学 血液学 血液学
- 发展生物学 发展生物学
- 神经科学是一个神经科学.
背景情况:
- 血液构造从静止的造血干细胞 (HSC) 生成所有的血细胞.
- 调节高细胞平衡和功能的机制尚未完全理解.
- 高血压细胞需要自我更新和扩展能力,以满足生理需求.
研究的目的:
- 调查神经营养因子受体RET在HSC调节中的作用.
- 阐明HSC中RET下游的信号通路.
- 探索RET激活在HSC移植中的治疗潜力.
主要方法:
- 在HSC及其环境中对RET表达的分析.
- 在小鼠模型中对Ret进行基因切除,以评估HSC功能.
- 评估HSC的生存,扩张,分化和移植潜力.
- 研究下游信号通路,包括p38 MAPK,CREB,Bcl2和Bcl2l1.1.
- 评估神经营养因子对人类带血祖先的影响.
主要成果:
- HSCs表达RET,其配体存在于HSC微环境中.
- 逆移除损害了HSC的存活率和数量,影响了应激反应和复合.
- RET信号激活p38 MAPK和CREB,导致Bcl2和Bcl2l1的表达,这对HSC的生存至关重要.
- 强制表达Bcl2或Bcl2l1可以挽救Ret的原始基因功能.
- RET激活可以提高HSC的存活率,扩张率和移植效率.
- 神经营养不良因素增强了人类带血原体的扩张和移植.
结论:
- 神经营养因子受体RET是HSC生存,扩张和功能的关键调节者.
- 通过p38 MAPK/CREB和Bcl2/Bcl2l1进行RET信号传输,对于高血压细胞的平衡和应激反应至关重要.
- RET激动剂代表了一种有前途的治疗策略,用于增强人类的高细胞移植结果.
更多相关视频
11:40Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation
Published on: October 20, 2014
10:25Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells
Published on: August 9, 2019
相关概念视频
Regulation of Hematopoietic Stem Cells
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Regulation of Angiogenesis and Blood Supply
Multipotency of Hematopoietic Stem Cells
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
